• Extensive experience in the clinical use of botulinum toxin for both aesthetic and therapeutic indications. Her expertise includes assessment, dosing rationale, injection technique, anatomical considerations, and the management of toxin‑related complications.
• Skilled in evaluating adverse outcomes such as ptosis, asymmetry, unintended muscle weakness, and treatment failure, and in determining whether practitioner technique, product handling, and consent processes met accepted clinical and professional standards.

• extensive expertise in the use of dermal fillers, including advanced application of hyaluronic acid (HA) products and biostimulatory injectables.
•  A clinical background spanning assessment, treatment planning, complication management, and the evaluation of practitioner competence in these modalities.
• Highly experienced in recognising adverse events, managing complex filler‑related complications
• Assessment of  treatment techniques, product selection, and aftercare to meet accepted professional standards.
• Knowledge of HA rheology, injection anatomy, and biostimulator mechanisms of action informs her detailed and evidence‑based medico‑legal opinions.

• Experience in intralipotherapy, including the assessment, administration, and complication management of injectable fat‑dissolving treatments.

Adverse outcomes such as thread migration, infection, dimpling, nerve irritation, and asymmetry, and is able to evaluate whether treatment delivery met accepted clinical, regulatory, and professional standards.

•  Identification and management of complications arising from non‑surgical aesthetic treatments. 

•  Consent processes within non‑surgical aesthetic practice.
• Evaluating whether practitioners obtained valid, informed consent in line with professional, regulatory, and legal standards, including the adequacy of risk disclosure, treatment alternatives, post‑procedure expectations, and documentation.

• Evaluating scope of practice and professional conduct within nursing and non‑surgical aesthetic practice.
• assessment of  whether practitioners operated within their authorised competencies, adhered to NMC standards, and demonstrated the level of clinical judgement, accountability, and professional behaviour expected of registered nurses.  Analysis  and consideration of delegation, supervision, prescribing practice, record‑keeping, escalation, and adherence to national guidance, as well as the practitioner’s understanding of their own limitations.
• Evidence‑based opinion on whether actions fell within an appropriate scope of practice and whether professional conduct met the regulatory and ethical standards required.

• Analysis and consideration of prescribing practice within non‑surgical aesthetics, including the safe, evidence‑based use of prescription‑only medicines and the governance frameworks that underpin accountable prescribing.
• Evaluation of whether practitioners met the legal, professional, and regulatory requirements for assessment, diagnosis, prescribing, and follow‑up care.

• Identification  of  governance and regulatory failures within non‑surgical aesthetic practice
• Obligations under national standards, professional codes, and regulatory frameworks, including clinical governance systems, risk management processes, record‑keeping, supervision, and escalation pathways.
• Evidence‑based opinion on systemic and individual regulatory shortcomings, supporting the court in understanding how organisational and practitioner‑level failures impact patient safety and professional accountability.